Ovid Therapeutics Inc. SEC filings OVID
Ovid Therapeutics Inc. has 532 filings in SEC EDGAR's recent list, going back to Mar 18, 2015. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Apr 27, 2026 | — |
| S-3 | Shelf registration | Apr 21, 2026 | — |
| S-8 | Employee stock plan registration | Mar 18, 2026 | — |
| 424B3 | Prospectus | Dec 22, 2025 | — |
| S-3 | Shelf registration | Dec 15, 2025 | — |
| S-8 | Employee stock plan registration | May 14, 2024 | — |
| 424B5 | Prospectus supplement | Nov 15, 2023 | — |
| S-3 | Shelf registration | Nov 3, 2023 | — |
| S-8 | Employee stock plan registration | May 5, 2023 | — |
| S-8 POS | Filing | Mar 16, 2022 | — |
| S-8 | Employee stock plan registration | Mar 15, 2022 | — |
| S-8 | Employee stock plan registration | Mar 18, 2021 | — |
| 424B5 | Prospectus supplement | Nov 20, 2020 | — |
| S-3 | Shelf registration | Nov 13, 2020 | — |
| 424B5 | Prospectus supplement | Aug 26, 2020 | — |
| S-8 | Employee stock plan registration | Mar 11, 2020 | — |
| 424B5 | Prospectus supplement | Nov 12, 2019 | — |
| 424B5 | Prospectus supplement | Oct 8, 2019 | — |
| 424B5 | Prospectus supplement | Oct 8, 2019 | — |
| 424B5 | Prospectus supplement | Oct 3, 2019 | — |
| 424B5 | Prospectus supplement | Oct 3, 2019 | — |
| S-8 | Employee stock plan registration | Aug 7, 2019 | — |
| 424B5 | Prospectus supplement | Feb 22, 2019 | — |
| 424B5 | Prospectus supplement | Feb 22, 2019 | — |
| 424B5 | Prospectus supplement | Feb 19, 2019 | — |
| 424B5 | Prospectus supplement | Feb 19, 2019 | — |
| S-3 | Shelf registration | Jun 1, 2018 | — |
| S-8 | Employee stock plan registration | Mar 29, 2018 | — |
| S-8 | Employee stock plan registration | May 22, 2017 | — |
| 424B4 | Prospectus | May 5, 2017 | — |
| S-1/A | Amended registration statement | May 3, 2017 | — |
| S-1/A | Amended registration statement | May 2, 2017 | — |
| S-1/A | Amended registration statement | Apr 25, 2017 | — |
| S-1/A | Amended registration statement | Apr 18, 2017 | — |
| S-1 | Registration statement | Apr 10, 2017 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OVID (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1636651
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.